IDEXX falls on annual revenue forecast cut
** Shares of animal health diagnostic equipment maker IDEXX
Laboratories IDXX.O fall ~8.3% to $413.69
** Co expects full-year revenue between $3.87 bln and $3.89
bln, down $38 million at the midpoint from its previous forecast
** IDEXX's Q3 revenue of $976 million misses analysts'
average expectation of $979.2 million - LSEG
** Stock down 26.6% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))